After two years characterized by layoffs, pipeline reorganizations, FDA delays and clinical holds, Novavax CEO John Jacobs ...

SINGAPORE: The updated JN.1 Novavax/Nuvaxovid COVID-19 vaccine will be offered under the national vaccination programme at selected Healthier SG general practitioner (GP) clinics until Apr 30.

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced progress in Q4 2024 advancing its corporate growth strategy through ...

shares of this vaccine maker have returned +3.5%, compared to the Zacks S&P 500 composite's +2.1% change. During this period, the Zacks Medical - Biomedical and Genetics industry, which Novavax ...

"Today, we announce the beginning of an exciting new chapter for Novavax with the launch of a strategically important partnership with one of the world's leading vaccine companies," NVAX CEO John ...

Shares of this vaccine maker have returned +23.4% over the past month versus the Zacks S&P 500 composite's -2.8% change. The Zacks Medical - Biomedical and Genetics industry, to which Novavax ...

Back in November 2023, pharmaphorum travelled to Uppsala, Sweden, for a Novavax press conference, the company celebrating a decade of doing what it does best: vaccines. From COVID-19 to malaria ...

In July last year, Moderna was awarded $176mn by the US government to develop a bird flu vaccine using its messenger-RNA technology. Novavax and CureVac also have early-stage bird flu vaccines ...

Using its massive manufacturing clout, the country purchased 500 million doses of the Oxford University-AstraZeneca vaccine candidate, one billion from the American company Novavax and 100 million ...

These are jabs developed by Pfizer Biontech, Moderna and AstraZeneca. While the Novavax and the Sanofi GSK vaccines will not be part of the module, it will look at the circumstances surrounding ...